Stokes Capital Advisors LLC Increases Stake in Colgate-Palmolive Company $CL

Stokes Capital Advisors LLC lifted its position in Colgate-Palmolive Company (NYSE:CL) by 17.1% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 79,107 shares of the company’s stock after purchasing an additional 11,553 shares during the period. Stokes Capital Advisors LLC’s holdings in Colgate-Palmolive were worth $6,324,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Brighton Jones LLC raised its stake in shares of Colgate-Palmolive by 4.4% during the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after acquiring an additional 450 shares during the last quarter. Aptus Capital Advisors LLC lifted its holdings in Colgate-Palmolive by 24.3% in the 1st quarter. Aptus Capital Advisors LLC now owns 21,986 shares of the company’s stock worth $2,060,000 after buying an additional 4,296 shares during the period. Legacy Financial Advisors Inc. grew its position in shares of Colgate-Palmolive by 7.3% in the 1st quarter. Legacy Financial Advisors Inc. now owns 2,626 shares of the company’s stock worth $246,000 after buying an additional 179 shares during the last quarter. T. Rowe Price Investment Management Inc. increased its stake in shares of Colgate-Palmolive by 103.8% during the first quarter. T. Rowe Price Investment Management Inc. now owns 10,218 shares of the company’s stock valued at $958,000 after buying an additional 5,204 shares during the period. Finally, TFB Advisors LLC purchased a new stake in Colgate-Palmolive in the first quarter worth $212,000. 80.41% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages have commented on CL. Citigroup decreased their price objective on shares of Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating for the company in a report on Monday, November 3rd. Raymond James Financial cut their price objective on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a research report on Monday, October 20th. Argus reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Thursday, December 11th. UBS Group lowered their target price on Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating for the company in a research note on Monday, November 3rd. Finally, The Goldman Sachs Group reduced their price target on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a research note on Thursday, October 2nd. Ten research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $88.81.

Colgate-Palmolive Trading Down 2.5%

Colgate-Palmolive stock opened at $77.73 on Friday. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18. The company has a market capitalization of $62.66 billion, a price-to-earnings ratio of 21.77, a price-to-earnings-growth ratio of 5.68 and a beta of 0.30. The business’s fifty day simple moving average is $78.31 and its two-hundred day simple moving average is $83.22. The company has a current ratio of 0.93, a quick ratio of 0.60 and a debt-to-equity ratio of 5.90.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a return on equity of 333.39% and a net margin of 14.47%.The firm had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.17 billion. During the same quarter in the previous year, the firm earned $0.91 EPS. Colgate-Palmolive’s quarterly revenue was up 1.9% compared to the same quarter last year. As a group, equities analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st will be issued a dividend of $0.52 per share. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.7%. Colgate-Palmolive’s dividend payout ratio is presently 58.26%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.